About Careers MedBlog Contact us

Chemotherapy Drugs Could Improve Tumor Response to Immune Checkpoint Therapy

by Dr. Trupti Shirole on February 17, 2016 at 10:38 PM
Font : A-A+

 Chemotherapy Drugs Could Improve Tumor Response to Immune Checkpoint Therapy

The use of certain traditional chemotherapy drugs may expand the number of tumors that respond to one of today's most promising cancer therapies - immune checkpoint blockade. Inducing the infiltration of cytotoxic T cells (CTLs) - immune cells that kill cancer cells and cells that are infected or in other ways damaged - into lung tumors sensitized otherwise unresponsive tumors to checkpoint blockade in animal models, suggested researchers from the Massachusetts General Hospital (MGH) Center for Systems Biology. The study is published in Immunity.

Mikael Pittet, of the MGH Center for Systems Biology, senior author of the Immunity paper, said, "Immune checkpoint blockade has revolutionized cancer therapy because it can durably control tumor progression, even in patients who fail to respond to other treatments. But the drawback is that it only benefits a fraction of patients. We have found a way to make unresponsive lung tumors sensitive to checkpoint blockade immunotherapy and achieve long-lasting control of tumor growth in these animal models."


One of the ways that tumors evade the immune system is by activating immune checkpoints - molecules that normally function to suppress the activity of CTLs. While clinical trials of drugs that block immune checkpoints have induced long-term control of several types of cancer, they have done so in only a minority of patients. The reason for this selective response is unclear, but evidence has suggested that patients whose tumors already contain CTLs are more likely to benefit.

The MGH-based team tested combinations of several FDA-approved chemotherapy drugs with the goal to find some that induce CTL infiltration within the tumors of several lung cancer mouse models. Only the combination of oxaliplatin and cyclophosphamide (Oxa-Cyc) did so. The researchers then showed that lung tumors in mice treated with Oxa-Cyc alone grew more slowly. Tumor control required not only CTL infiltration into tumors but also an increased activity of the innate immune system within the tumor microenvironment, which also was stimulated by Oxa-Cyc treatment. Furthermore, combining Oxa-Cyc treatment with immune checkpoint blockade durably controlled tumor growth in the lung cancer mouse models, which neither treatment was able to do alone. The investigators also identified other chemotherapy drugs that, when combined with immune checkpoint therapies in mice, could delay progression of other cancer types, including fibrosarcoma and colon cancer.

Pittet said, "The genetic mouse model of lung cancer used in this study is notoriously resistant to today's cancer treatments, in contrast to many other models that are sensitive to several chemotherapy agents. We hope this model replicates treatment-resistant disease enough so that our findings can be translated to patients, but clinical trials are needed to examine whether that will be the case. Since the drugs shown to work in this study are all FDA-approved, the combination could be quickly tested in patients with lung cancer. We also plan to explore whether precision medicine approaches, which could identify drugs that best promote tumor infiltration by CTLs in a given patient, could extend the benefits of checkpoint blockade to even more patients."

Source: Eurekalert

News A-Z
What's New on Medindia
Test Your Knowledge on Sugar Intake and Oral Health
Test  Your Knowledge on Heart
Test Your Knowlege on Genes
View all
Recommended Reading
News Archive
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Chronic Lymphocytic Leukemia Hodgkins Lymphoma Non-Hodgkins Lymphoma Chemotherapy Chemotherapy Drugs Reiki and Pranic Healing Tumor Markers For Cancer Diagnosis and Prognosis Peritoneal Cancer Myasthenia Gravis 

Most Popular on Medindia

Sinopril (2mg) (Lacidipine) Drug Interaction Checker Selfie Addiction Calculator Post-Nasal Drip A-Z Drug Brands in India Noscaphene (Noscapine) Diaphragmatic Hernia The Essence of Yoga Nutam (400mg) (Piracetam) Find a Hospital
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use

Chemotherapy Drugs Could Improve Tumor Response to Immune Checkpoint Therapy Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests